Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Small nuclear ribonucleoprotein polypeptide N upstream reading frame protein (SNURF) is a small, highly conserved nuclear protein encoded upstream of the SNRPN gene within the Prader–Willi syndrome critical region on chromosome 15q11–q13[1][3]. The SNURF gene is part of a complex locus involved in genomic imprinting, producing bicistronic transcripts that also encode SNRPN, as well as serving as a host for several small nucleolar RNAs (snoRNAs)[1][3]. The locus, and specifically the SNURF gene, is central to establishing parental (paternal) allele-specific gene expression patterns that are crucial for neurodevelopmental processes. Disruptions—such as deletions or failures in imprinting regulation—in this region can cause Prader–Willi or Angelman syndrome[1][3]. SNURF encodes a 71-amino-acid, highly basic (arginine-rich, nuclear-localized) protein, but its precise biochemical role remains unclear[3]. It is not a receptor, enzyme, transporter, or druggable target, and there are no known drugs that interact with it. Common mutations in this region are important diagnostic markers for imprinting disorders affecting neurodevelopment[1][3]. The abbreviation "SNURFL," "Putative SNURF-like protein," or "CXorf19" may refer to predicted or hypothetical homologs but are not established canonical names for a distinct protein-coding gene in humans. There is likely confusion or mislabeling—"SNRPN upstream open reading frame like" does not refer to an established therapeutic target or functional protein; rather, the canonical entry is SNURF[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide N upstream reading frame protein (SNURF).